Pegfilgrastim vs. filgrastim for supportive care after autologous stem cell transplantation: can we decide?
about
A randomized, non-inferiority study comparing efficacy and safety of a single dose of pegfilgrastim versus daily filgrastim in pediatric patients after autologous peripheral blood stem cell transplantLong-active granulocyte colony-stimulating factor for peripheral blood hematopoietic progenitor cell mobilization.Italian consensus conference for the outpatient autologous stem cell transplantation management in multiple myeloma.Cost effectiveness of pegfilgrastim versus filgrastim after high-dose chemotherapy and autologous stem cell transplantation in patients with lymphoma and myeloma: an economic evaluation of the PALM Trial.A comparison of the effect of xinruibai versus filgrastim on hematopoietic reconstruction after allogeneic hematopoietic stem cell transplantation.
P2860
Pegfilgrastim vs. filgrastim for supportive care after autologous stem cell transplantation: can we decide?
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Pegfilgrastim vs. filgrastim f ...... ransplantation: can we decide?
@en
Pegfilgrastim vs. filgrastim f ...... ransplantation: can we decide?
@nl
type
label
Pegfilgrastim vs. filgrastim f ...... ransplantation: can we decide?
@en
Pegfilgrastim vs. filgrastim f ...... ransplantation: can we decide?
@nl
prefLabel
Pegfilgrastim vs. filgrastim f ...... ransplantation: can we decide?
@en
Pegfilgrastim vs. filgrastim f ...... ransplantation: can we decide?
@nl
P2860
P1476
Pegfilgrastim vs. filgrastim f ...... ransplantation: can we decide?
@en
P2093
Irene S Kourbeti
Panayiotis D Ziakas
P2860
P356
10.1111/J.1399-0012.2011.01532.X
P577
2011-10-31T00:00:00Z